Patients with elevated levels of CTSS are more susceptible to DLBCL, which corresponds to a 20.6% increased hazard (ORIVW = 1.206, 95% CI 1.054–1.380, P = .006). The gene discussed is CTSS; the disease is diffuse large B-cell lymphoma.